DermaWound Wound Care Venous Stasis

BENZOCAINE HYDROCHLORIDE TOPICAL HUMAN OTC DRUG

DermaWound Wound Care Venous Stasis is an FDA drug label for the active ingredient BENZOCAINE HYDROCHLORIDE manufactured by Progressive Doctors, LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231215.

Generic name
BENZOCAINE HYDROCHLORIDE
Manufacturer
Progressive Doctors, LLC
Product type
HUMAN OTC DRUG
Route
TOPICAL
Dosage form
N/A
NDC
57554-120
Application
M017
Label effective
20231215

Active ingredients

Active ingredient Benzocaine Hydrochloride (1.27%)

Indications & Usage

Uses topical pain relief of minor cuts scrapes burns

Dosage & Administration

Directions Gently clean around the affected area Prior to application of DermaWound , evaluate the wound or ulcer to insure no excessive bleeding is present. . ® Never wipe out the ulcer Apply a moderate amount of DermaWound directly to affected area. ® Deeper or "tunneling" wounds may require packing and/or sides coated with additional DermaWound and sterile gauze. ® Apply additional sterile gauze to absorb exudates, if needed. Change Dressing 2 or 3 times daily or as directed by a physician. May require supervision of a health care professional in the management of chronic & acute wound care, pressure sores, diabetic ulcers, surgical wounds & indwelling catheters.

Contraindications

Not available.

Warnings

Warnings For external use only

Adverse Reactions

Not available.